2012
Recovery of left ventricular function after percutaneous revascularization of a left main chronic total occlusion
Khanna P, Stilp E, Pfau S. Recovery of left ventricular function after percutaneous revascularization of a left main chronic total occlusion. Catheterization And Cardiovascular Interventions 2012, 80: 310-315. PMID: 22553190, DOI: 10.1002/ccd.24322.Peer-Reviewed Original ResearchMeSH KeywordsAgedCardiomyopathy, DilatedChronic DiseaseCoronary AngiographyCoronary OcclusionDrug-Eluting StentsHumansMaleMyocardial Perfusion ImagingPercutaneous Coronary InterventionPositron-Emission TomographyRecovery of FunctionStroke VolumeTreatment OutcomeVentricular Dysfunction, LeftVentricular Function, LeftConceptsLeft ventricular ejection fractionPercutaneous coronary interventionCoronary artery diseaseMain percutaneous coronary interventionChronic total occlusionSurgical revascularizationTotal occlusionThree-vessel coronary artery diseaseDepressed left ventricular ejection fractionMultivessel coronary artery diseaseMultivessel percutaneous coronary interventionIntermediate-term mortalityLeft ventricular dysfunctionVentricular ejection fractionLeft ventricular functionLeft ventricular sizeComplete revascularizationPercutaneous revascularizationTerm mortalityVentricular dysfunctionCoronary interventionArtery diseaseEjection fractionImproved survivalMedical therapy
2003
Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic cardiomyopathy
Samady H, Liu Y, Choi CJ, Ragosta M, Pfau SE, Cleman MW, Powers ER, Kramer CM, Wackers F, Beller GA, Watson DD. Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic cardiomyopathy. The American Journal Of Cardiology 2003, 91: 807-811. PMID: 12667565, DOI: 10.1016/s0002-9149(03)00013-4.Peer-Reviewed Original ResearchMeSH KeywordsAgedBody Surface Potential MappingCardiomyopathiesCell SurvivalElectrophysiologic Techniques, CardiacFemaleHumansMaleMiddle AgedMyocardial IschemiaMyocardiumPredictive Value of TestsRadiopharmaceuticalsRestROC CurveSensitivity and SpecificitySeverity of Illness IndexStatistics as TopicStress, PhysiologicalStroke VolumeTechnetium Tc 99m SestamibiTomography, Emission-Computed, Single-PhotonVentricular Dysfunction, LeftConceptsSevere ischemic cardiomyopathyIschemic cardiomyopathyViable myocardiumMyocardial viabilityDipyridamole single-photon emissionUnipolar voltageDysfunctional myocardial segmentsBipolar voltageSingle photon emissionDipyridamole SPECTDipyridamole technetiumQuantitative technetiumInducible ischemiaNonviable segmentsNonviable myocardiumElectromechanical mappingMyocardial segmentsTracer uptakePatientsViable segmentsLogistic regressionCardiomyopathyMyocardiumIschemiaSPECT
2001
Serum complement activation in congestive heart failure
Clark D, Cleman M, Pfau S, Rollins S, Ramahi T, Mayer C, Caulin-Glaser T, Daher E, Kosiborod M, Bell L, Setaro J. Serum complement activation in congestive heart failure. American Heart Journal 2001, 141: 684-690. PMID: 11275938, DOI: 10.1067/mhj.2001.113758.Peer-Reviewed Original ResearchConceptsCongestive heart failureSymptomatic heart failureC5b-9 levelsHeart failureClinical outcomesC5b-9Control patientsNew York Heart Association class IV symptomsComplement activationAge-matched control patientsClass IV symptomsCombined clinical outcomeAdverse clinical outcomesVentricular ejection fractionTerminal complement complex C5b-9Terminal complement activationComplement complex C5b-9Serum complement activationTerminal complement complexAdverse eventsCardiopulmonary bypassEjection fractionSerum levelsMyocardial injuryMyocardial infarction